Important Considerations Before Starting Leqvio Treatment
Before initiating treatment with Leqvio, it is crucial to discuss important health information with your doctor or pharmacist. This ensures the medication is appropriate for your specific health profile and circumstances.
Leqvio Use During Pregnancy
The safety of Leqvio during pregnancy has not been established. Studies on its use in pregnant individuals are lacking. It is important to understand that cholesterol plays a vital role in fetal development. Given that Leqvio works by lowering cholesterol levels, there is a potential risk of harm to a developing fetus if the drug is administered during pregnancy. Consequently, healthcare providers typically advise against prescribing Leqvio to pregnant individuals.
If you are pregnant or planning to become pregnant, it is essential to consult your doctor to explore alternative treatment options. Should you become pregnant while undergoing Leqvio treatment, your doctor will likely recommend discontinuing the medication.
Leqvio Use While Breastfeeding
The safety of Leqvio for individuals who are breastfeeding remains unknown. There is currently no information regarding whether the drug can pass into breast milk or if it could affect a breastfed infant. Therefore, if you are breastfeeding or intend to breastfeed, it is advisable to discuss your treatment options thoroughly with your doctor.
Key Health Precautions and Medical History
Before starting Leqvio, a comprehensive review of your medical history with your doctor is necessary. Several factors warrant consideration.
Allergic Reactions: If you have a history of allergic reactions to Leqvio or any of its components, your doctor will likely not prescribe this medication. In such cases, your doctor can recommend alternative treatments better suited for you.
Severe Liver Problems: The safety and effectiveness of Leqvio have not been studied in individuals with severe liver problems. If you have a severe liver condition, it is imperative to discuss with your doctor whether Leqvio is an appropriate treatment choice for you.
Leqvio and Other Cholesterol-Lowering Medications (Repatha, Praluent)
It is generally not recommended to use Leqvio concurrently with evolocumab (Repatha) or alirocumab (Praluent) for lowering LDL cholesterol. The combined effect of Leqvio with these specific drugs has not been adequately studied, meaning their safety and efficacy when used together for cholesterol reduction are unknown.
Repatha and Praluent are classified as PCSK9 inhibitors, which reduce cholesterol by blocking a protein called PCSK9 in the body. While Leqvio belongs to a different class of cholesterol-lowering drugs, it operates through a similar mechanism by preventing the liver from producing PCSK9.
If your current treatment with Repatha or Praluent is not sufficiently lowering your cholesterol, your doctor might suggest discontinuing it and switching to Leqvio. Conversely, if Leqvio is not proving effective for you, your doctor may recommend transitioning to one of these other medications. Always consult your doctor to discuss your treatment plan and available options.
Leave a Reply